Aya Mohamed: 15-Year SOFT/TEXT Data for Premenopausal HR+ Breast Cancer
Aya Mohamed, Medical Oncologist, Associate Lecturer of Medical Oncology, Member of ASCO, shared on X: “SOFT/TEXT at 15 Years One size does not fit all. Exemestane + OFS should be […]
Read the full articleYou might also wanna read
CME | Hot Takes and Flashbacks of Menopause
In this episode of CME On the Go, our hosts revisit menopause through a case of a 51-year-old with seven months of amenorrhea, vasomotor and
Untitled
Boucheron P, Anele A, Offiah AU, Zietsman A, Galukande M, Parham G, Pinder LF, Anderson BO, Foerster M, Schüz J, Dos-Santos-Silva I, McCorma
Young women diagnosed with breast cancer within 3 years of childbirth may face more aggressive disease, UCLA study finds
A gene expression test identifies the first three years after childbirth as a potential window of higher biological risk.
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
CME | Menopause, Minus the Mystery: What Every Clinician Should Know
In this re-released episode of CME on the Go, originally published on 9/2/2025, our hosts delve into menopause, providing family physicians
CME | Menopause, Minus the Mystery: What Every Clinician Should Know
In this episode of CME on the Go our hosts delve into menopause, providing family physicians with essential insights, treatment options, and
Comments
Sign in to join the conversation.
No comments yet. Be the first.